Colocalization of ribonuclear inclusions with muscle blind like-proteins in a family with myotonic dystrophy type 2 associated with a short CCTG expansion

Journal of the Neurological Sciences

Volumn 275, Issue 1-2, 2008, Pages 159-163

  Lucchiari, S ^a   Pagliarani, S ^a   Corti, S ^a   Mancinelli, E ^a   Servida, M ^a   Fruguglietti, E ^a   Sansone, V ^b   Moggio, M ^a   Bresolin, N ^a,c   Comi, G P ^a   Meola, G ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS POLICLINICO SAN DONATO   (Italy)

^c SCIENTIFIC INSTITUTE   (Italy)

Author keywords

CCTG expansion; Muscle blind; Myotonic dystrophy type 2

Indexed keywords

CREATINE KINASE; MUSCLE PROTEIN; MUTANT PROTEIN; RIBONUCLEOPROTEIN; RNA;

ADULT; ANAMNESIS; ARTICLE; BLOOD SAMPLING; CASE REPORT; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; ELECTROPHYSIOLOGY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE AMPLIFICATION; GENE PROBE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; MALE; MOLECULAR CLONING; MYOTONIC DYSTROPHY; PHENOTYPE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; ZNF9 GENE;

ADULT; CREATINE KINASE; DNA REPEAT EXPANSION; ELECTROMYOGRAPHY; FAMILY HEALTH; FEMALE; HUMANS; INDOLES; INTRANUCLEAR INCLUSION BODIES; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYOTONIC DYSTROPHY; RNA-BINDING PROTEINS;

EID: 55849084632     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.08.007     Document Type: Article

References (16)

1. Wheeler T.M., and Thornton C.A. Myotonic dystrophy: RNA-mediated muscle disease. Curr Opin Neurol 20 5 (2007) 572-576
2. Schara U., and Schoser B.G. Myotonic dystrophies type 1 and 2: a summary on current aspects. Semin Pediatr Neurol 13 2 (2006) 71-79
3. Day J.W., Ricker K., Jacobsen J.F., Rassmussen L.J., Dick K.A., Kress W., et al. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 60 4 (2003) 657-664
4. Liquori C.L., Ricker K., Moseley M.L., Jacobsen J.F., Kress W., Naylor S.L., et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293 5531 (2001) 864-867
5. Gerbasi V.R., and Link A.J. The myotonic dystrophy type 2 protein ZNF9 is part of an ITAF complex that promotes cap-independent translation. Mol Cell Proteomics 6 6 (2007) 1049-1058
6. V. Dubowitz, Muscle biopsy: A practical approach. Balliére-Tindall W. B. Saunders, London, Toronto 1985.
7. Cardani R., Mancinelli E., Sansone V., Rotondo G., and Meola G. Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy. Eur J Histochem. 48 (2004) 437-442
8. Cardani R., Mancinelli E., Rotondo G., Sansone V., and Meola G. Muscleblind-.like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2. Eur J Histochem 50 3 (2006) 177-182
9. Suominen T., Schoser B., Raheem O., Auvinen S., Walter M., Krahe R., et al. Report of the 6th International Myotonic Dystrophy Consortium Meeting workshop, 12-15 September 2007, Milan, Italy vol. O46 (2007) 15
10. Harper P.S. Myotonic dystrophy. 3rd ed. (2001), W. B. Saunders, London
11. Liquori C.L., Ikeba Y., Weatherspoon M., Ricker K., Schoser B.G., Dalton J.C., et al. Myotonic dystrophy type 2: human founder haplotype and evolutionary conservation of the repeat tract. Am J Hum Genet 73 4 (2003) 849-862
12. Meola G., and Moxley R.T. Myotonic dystrophy type 2 and related myotonic disorders. J Neurol 251 (2004) 1173-1182
13. Moxley R.T., and Meola G. The myotonic dystrophies. In: Rosenberg R.N., Di Mauro S., Paulson H.L., Ptacek L., and Nestler E.J. (Eds). The molecular and genetic basis of neurologic and psychiatric disease. 4th Ed (2008), Philadelphia, Lippincot Williams Chapter 47
14. Botta A., Bonifazi E., Vallo L., Gennarelli M., Garrè C., Salehi L., et al. Italian guidelines for molecular analysis in myotonic dystrophies. Acta Myol 25 1 (2006) 23-33
15. Davis B.M., McCurrach M.E., Taneja K.L., Singer R.H., and Housman D.E. Expansion of a CUG trinucleotide repeat in the 3' untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc Natl Acad Sci USA. 8;94 14 (1997) 7388-7393
16. Osborne R.J., and Thornton C.A. RNA dominant diseases. Hum Mol Genet 15 (2006) R162-R169 (special n. 2)